SOURCE: BioTech Medics, Inc.

April 22, 2008 08:00 ET

BioTech Medics Announces Opening of Another Clinic

DALLAS, TX--(Marketwire - April 22, 2008) - BioTech Medics, Inc. (PINKSHEETS: BMCS) announced today the opening of its newest affiliate center: Life Vessel of Santa Fe, a Wellness & Pain Management Center. This is another of a series of BioTech affiliated centers nationwide.

Keith Houser, Chairman/CEO of BioTech said, "Life Vessel of Santa Fe is our premier center that will become a model for more of our BioTech L3aser™ Pain Management & Wellness Centers nationwide. Life Vessel offers the benefits of traditional western medicine with a full-time licensed medical doctor and chiropractor and 3 certified laser technicians and alternative medicine." The center will be open 6 days a week. Additional information can be found on the web at

Specifically, Life Vessel offers the exclusive and proprietary BioTech L3aser™ Pain Management Treatment Protocols using an FDA 510(k) cleared high-powered 21st Century medical therapeutic laser. The medical laser is a proven, quick, safe, effective non-invasive medical device and treatment that may reduce and/or eliminate pain.

Persons with back pain, carpal tunnel, knee pain, arthritis or 90 other muscular, skeletal or nerve pain ailments can be treated in any one of BioTech's pain centers nationwide. Unlike, "cold lasers," BioTech's high-powered lasers are patent protected with up to 10,000 times more power than some cold lasers. Patients feel the high-powered laser as they are being treated over their area of pain.

Additional BioTech affiliated centers are available in the USA. Medical Practitioners and investors interested in becoming a part of the BioTech affiliated centers should phone the BioTech Investor Relations or email the company:

BioTech medics is a ten year old company that has developed exclusive and proprietary high-powered therapeutic laser pain management protocols, training and certification for laser technicians, the creation of BioTech pain management centers to be developed nationwide, patents for SHBAN™ Antimicrobial Solution, and BioBody Products.

Safe Harbor for Forward-Looking Statements.

This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. This is not an offer to buy or sell any security.

Contact Information

  • Contact:

    Investor Relations